immatics biotechnologies GmbH
Patents, Design & Utilities

Last updated:

List of all immatics biotechnologies GmbH patents 820 in total

Status Patent
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: METHOD OF TREATING WITH A PEPTIDE External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, IN PARTICULAR CHRONIC LYMPHOID LEUKEMIA (CLL) External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: NOVEL PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 15 Oct 2020
Grant
Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) External link
Filling date: 8 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: T cell receptors and immune therapy using the same External link
Filling date: 8 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: T cell receptors and immune therapy using the same against prame positive cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 8 Sep 2025 Issue date: 13 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 8 Oct 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 6 Oct 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 6 Oct 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 8 Sep 2025 Issue date: 6 Oct 2020
Grant
Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC External link
Filling date: 8 Sep 2025 Issue date: 6 Oct 2020
Application
Utility: NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 24 Sep 2020
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 24 Sep 2020

Showing 450 to 500 of 820 patents.